E
MindBio Therapeutics Corp. MBIO
CNSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -201.55% -- -- -- --
Total Revenue -201.55% -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -201.55% -- -- -- --
SG&A Expenses -84.16% -83.74% -81.98% -- --
Depreciation & Amortization 6,575.00% 97.50% -166.67% -- --
Other Operating Expenses -44.20% -44.20% 19.03% -- --
Total Operating Expenses -82.39% -83.05% -80.75% -- --
Operating Income 74.93% 82.96% 80.66% -- --
Income Before Tax 84.61% 93.67% 90.48% -- --
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 84.61% 93.67% 90.48% -- --
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 1,100.00% -300.00% -- -- --
Net Income 84.70% 93.66% 90.48% -- --
EBIT 74.93% 82.96% 80.66% -- --
EBITDA 145.55% 204.79% 166.13% -- --
EPS Basic 80.54% 94.19% 92.46% -- --
Normalized Basic EPS 79.78% 93.88% 91.98% -- --
EPS Diluted 80.54% 94.19% 92.46% -- --
Normalized Diluted EPS 79.78% 93.88% 91.98% -- --
Average Basic Shares Outstanding -9.08% -2.78% 12.40% -- --
Average Diluted Shares Outstanding -9.08% -2.78% 12.40% -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings